Name: TMDX Income Statement - Transmedics Group. Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

TMDX - Transmedics Group. Inc.

USD | NASDAQ | Healthcare

TMDX Income Statement - Transmedics Group. Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18
Revenues
Revenues	173.9	160.8	143.8	157.4	143.5	121.6	108.8	114.3	96.9	81.2	66.4	52.5	41.6	31.4	25.7	20.5

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenues
Revenues	635.9	605.5	441.5	241.6	93.5	30.3	25.6	23.6	13.0	-
Cost of Revenue	260.2	242.7	179.5	87.5	28.2	9.1	9.0	9.7	7.3	-
Gross Profit	375.7	362.8	262.1	154.1	65.3	21.2	16.6	13.9	5.7	-
Operating Expenses
Research & Development	76.8	69.1	56.0	36.1	26.8	22.3	18.8	19.9	13.7	-
Selling General & Administrative	204.5	185.2	168.6
Operating Income
Operating Income	94.4	108.6	37.5	(28.7)	(31.4)	(39.4)	(26.4)	(29.6)	(20.2)	-
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-
Interest Expense	17.5	13.8	14.4	10.8
Tax & Net
Income Tax Expense	(82.6)	(82.8)	0.3	(1.6)	0.1	-	0.0	0.0	0.0	0.0
Net Income From Continuing Ops	171.9	190.3	35.5
Per Share
EPS Basic	5.00	5.60	1.07	(0.77)	(1.23)	(1.60)	(1.16)	-	-	-
EPS Diluted	4.75	4.87	1.01	(0.77)
Supplementary Data
EBITDA	-	135.8	57.3	(20.6)	(28.0)	(37.6)	(24.8)	(28.4)	(19.5)	-
EBIT	94.4	108.6	37.5	(28.7)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	24.9	20.7	15.3	15.9	17.2	16.5	14.3	13.9	11.4	10.8	11.1	8.3	5.9	5.8	6.8	6.7	7.5	6.3	5.2	6.3	4.5	4.5	4.2	3.9	6.2	-	4.9	4.8	3.9	3.5	3.3	3.4	3.5
Selling General & Administrative	63.0	51.4	46.0	44.1	43.6	46.9	42.7	42.9	36.2	34.6	30.7	29.4	25.0	21.7	16.9	17.4
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	11.9	-	-	-	6.1	-	-	-	4.3	-	-	-	1.3	-	-	-
Amortization of Intangibles	-	(0.1)	0.1	0.1	0.1	(0.1)	0.1	0.1	0.1	-	-	-	-	-	-	-	-
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	87.9	72.1	61.3	60.0	60.8	63.4	56.9	56.8	47.5	45.3	69.0	37.6	30.9	27.5	23.7	24.1

Operating Income
Operating Income	13.3	21.3	23.3	36.6	27.4	8.6	3.9	12.5	12.4	2.6	(28.3)	(0.9)	(2.1)	(6.8)	(5.5)	(9.7)	(9.4)	(11.3)	(11.7)	(9.9)	(6.5)	(5.9)	(4.6)	(7.9)	(8.0)	-	(7.2)	(7.7)	(6.0)	(6.4)	(3.9)	(5.2)	(4.8)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	7.2	3.4	3.5	3.5	3.5	3.6	3.6	3.6	3.6	3.6	3.6	2.5	1.1	1.0	0.8	1.0	1.0	1.0
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	(4.8)	0.4	(0.3)	(0.4)	(0.8)	(1.7)	0.3	(0.4)	(0.0)	1.3	1.4	(0.1)	(0.5)	0.1	(1.9)	(1.8)	(1.2)
Pre-Tax Income	8.5	21.6	23.0	36.2	26.7	7.0	4.2	12.2	12.4	3.9	(26.9)	(1.0)	(2.6)	(6.7)	(7.4)	(11.5)	(10.6)

Tax & Net
Income Tax Expense	1.2	(83.8)	(1.3)	1.3	1.0	0.1	0.0	(0.0)	0.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income From Continuing Ops	7.3	105.4	24.3	34.9	25.7	6.9	4.2	12.2	12.2	4.0	(25.4)	(1.0)	(2.6)	(6.7)	(7.4)	(11.5)	(10.6)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	7.3	105.4	24.3	34.9	25.7	6.9	4.2	12.2	12.2	4.0	(25.4)	(1.0)	(2.6)	(6.7)	(7.4)	(11.5)	(10.6)
Net Income Attributable To Parent	7.3	105.4	24.3	34.9	25.7	6.9	4.2	12.2	12.2	4.0	(25.4)	(1.0)	(2.6)	(6.7)	(7.4)	(11.5)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	7.3	105.4	24.3	34.9	25.7	6.9	4.2	12.2	12.2	4.0	(25.4)	(1.0)	(2.6)	(6.7)	(7.4)

Per Share
EPS Basic	0.21	-	0.71	1.03	0.76	-	0.13	0.37	0.37	-	(0.78)	(0.03)	(0.08)	-	(0.25)	(0.41)	(0.38)	-	(0.47)	(0.39)	(0.29)	-	(0.19)	(0.36)	(0.42)	-	-	-	-	-	-	-	-
EPS Diluted	0.20	-	0.66	0.92	0.70	-	0.12	0.35	0.35	-	(0.78)	(0.03)	(0.08)	-	(0.25)	(0.41)	(0.38)	-
Shares Basic	34.4	-	34.1	33.9	33.7	-	33.4	33.1	32.8	-	32.6	32.5	32.3	-	30.2	28.0	28.0	-
Shares Diluted	36.2	-	40.7	40.6	39.9	-	35.7	35.3	34.7	-	32.6	32.5	32.3	-	30.2	28.0	28.0	-

Supplementary Data
EBITDA	25.2	-	-	-	33.6	-	-	-	16.7	-	-	-	(0.8)	-	-	-	(8.9)	-	-	-	(6.1)	-	-	-	(7.6)	-	-	-	(5.7)	-	-	-	(4.6)
EBIT	13.3	21.3	23.3	36.6	27.4	8.6	3.9	12.5	12.4	2.6	(28.3)	(0.9)	(2.1)	(6.8)	(5.5)	(9.7)	(9.4)	(11.3)	(11.7)